Skip to content

High MAP in Septic Shock With Hypertension

High Mean Arterial Pressure Target Improves Microcirculation in Septic Shock Patients With Previous Hypertension

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01443494
Enrollment
19
Registered
2011-09-29
Start date
2011-06-30
Completion date
2012-06-30
Last updated
2017-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic Shock

Keywords

septic shock, microcirculation, norepinephrine, fluid

Brief summary

We hypothesized that the increase in MAP from 65 mmHg to patients' usual level improved sublingual microcirculation.

Detailed description

The effect of mean arterial pressure (MAP) titration to higher level on microcirculation in septic shock patients with previous hypertension remains unknown. Our goal was to assess the effect of MAP titration to patients' usual level on microcirculation in septic shock patients with previous hypertension. We hypothesized that the increase in MAP from 65 mmHg to patients' usual level improved sublingual microcirculation.

Interventions

OTHERNE

norepinephine

Sponsors

Southeast University, China
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with septic shock for less than 24 hours * Fluid resuscitation was performed according to the guideline for treating septic shock to maintain the central venous pressure (CVP) for more than 8 mm Hg and central venous oxygen saturation for more than 70% * Patients requiring norepinephrine (NE) to maintain a MAP of 65 mm Hg. Septic shock patients with fluid resuscitation after CVP \> 8mmHg and mean blood pressure \> 65 mmHg

Exclusion criteria

* Pregnancy * Age \< 18 years * Inability to acquire the usual level of MAP * Refusal of consent by the patient or relative * Participation in other trials during the last three months * Hypertensive patients without hypertension treatment

Design outcomes

Primary

MeasureTime frameDescription
Mean Arterial PressureTarget MAP stabilization for 30 minAs chronic hypertensive patients were supposed to have undergone more blood pressure measurements in daily life than non-hypertensive ones, the averaged MAP acquired from patients' physical examination records of the last two years was registered and assumed as patients' usual level of MAP and target MAP. If patients' medical records were incomplete, a detailed enquiry about the target MAP to their next kin was performed. After stabilization for 30 min, basal measurements including hemodynamic and microcirculatory measurements were taken, 20 min apart, the NE doses were increased to titrate MAP to the target level. Patients were allowed to stabilize for 30 min before taking new measurements.

Secondary

MeasureTime frameDescription
Perfused Vessel DensityTarget MAP stabilization for 30 minIncreasing MAP from 65 mm Hg to target level. The sublingual microcirculation was measured by sidestream dark field, including the parameters of perfused vessel density

Countries

China

Participant flow

Participants by arm

ArmCount
Septic Shock Patients Despite EGDT With Hypertension
Patients with previous hypertension requiring norepinephrine to maintain a MAP of 65 mm Hg despite fluid resuscitation to central venous pressure above 8 mm Hg.
19
Total19

Baseline characteristics

CharacteristicSeptic Shock Patients Despite EGDT With Hypertension
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
14 Participants
Age, Categorical
Between 18 and 65 years
5 Participants
Region of Enrollment
China
19 participants
Sex: Female, Male
Female
6 Participants
Sex: Female, Male
Male
13 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 19
serious
Total, serious adverse events
0 / 19

Outcome results

Primary

Mean Arterial Pressure

As chronic hypertensive patients were supposed to have undergone more blood pressure measurements in daily life than non-hypertensive ones, the averaged MAP acquired from patients' physical examination records of the last two years was registered and assumed as patients' usual level of MAP and target MAP. If patients' medical records were incomplete, a detailed enquiry about the target MAP to their next kin was performed. After stabilization for 30 min, basal measurements including hemodynamic and microcirculatory measurements were taken, 20 min apart, the NE doses were increased to titrate MAP to the target level. Patients were allowed to stabilize for 30 min before taking new measurements.

Time frame: Target MAP stabilization for 30 min

ArmMeasureValue (MEAN)Dispersion
Septic Shock Patients Despite EGDTMean Arterial Pressure90 mmHgStandard Deviation 7
Secondary

Perfused Vessel Density

Increasing MAP from 65 mm Hg to target level. The sublingual microcirculation was measured by sidestream dark field, including the parameters of perfused vessel density

Time frame: Target MAP stabilization for 30 min

ArmMeasureValue (MEAN)Dispersion
Septic Shock Patients Despite EGDTPerfused Vessel Density12.08 vessels/mm^2Standard Deviation 2.52

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026